Related Experiment Video
Updated: Aug 11, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Sex Influence on Heart Failure Prognosis
Andrea Postigo1,2,3,4, Manuel Martínez-Sellés1,2,3,4,5
1Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Insights
Women with heart failure (HF) experience worse symptoms but have a better prognosis than men. This review explores sex-related differences in HF, aiming to explain women's survival advantage despite less treatment.
Area of Science:
- Cardiology
- Sex-based Medicine
Background:
- Heart failure (HF) affects 1-2% of developed populations, with women comprising ~50% of patients.
- Women with HF are often older and present with hypertension, valvular heart disease, and non-ischemic cardiomyopathy.
- Limited prospective HF studies on women necessitate inferences from male-centric trials and registries.
Purpose of the Study:
- To describe sex-related differences in heart failure (HF).
- To explore how these differences may explain the better prognosis observed in women with HF compared to men.
Main Methods:
- Review of existing literature and clinical trial data focusing on sex-based differences in HF.
- Analysis of patient demographics, comorbidities, clinical presentation, treatment patterns, and outcomes.
Main Results:
- Women exhibit greater clinical severity, more symptoms, and worse functional class in HF.
- Despite lower receipt of guideline-proven HF therapies, women demonstrate a survival advantage over men.
- Potential contributing factors to female survival, such as prior pregnancies, are considered.
Conclusions:
- Significant sex-related differences exist in heart failure (HF) regarding age, etiology, comorbidities, and clinical presentation.
- Women with HF have a better prognosis than men, a phenomenon not fully explained by current understanding or treatment disparities.
- Further research is needed to elucidate the biological and clinical factors, including potential roles of prior pregnancies, contributing to women's improved HF survival.
Abstract:
Heart failure (HF) affects 1-2% of the population in developed countries and ~50% of patients living with it are women. Compared to men, women are more likely to be older and suffer hypertension, valvular heart disease, and non-ischemic cardiomyopathy. Since the number of women included in prospective HF studies has been low, much information regarding HF in women has been inferred from clinical trials observations in men and data obtained from registries. Several relevant sex-related differences in HF patients have been described, including biological mechanisms, age, etiology, precipitating factors, comorbidities, left ventricular ejection fraction, treatment effects, and prognosis. Women have greater clinical severity of HF, with more symptoms and worse functional class. However, females with HF have better prognosis compared to males. This survival advantage is particularly impressive given that women are less likely to receive guideline-proven therapies for HF than men. The reasons for this better prognosis are unknown but prior pregnancies may play a role. In this review article we aim to describe sex-related differences in HF and how these differences might explain why women with HF can expect to survive longer than men.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions

